Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 111.71% vs 18.43% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 73.16% vs 47.37% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -17.20% vs 73.95% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 193.43% vs 73.70% in Mar 2024
Compare Profit and Loss Results of Speciality Medi.
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
58.00
1,908.00
-1,850.00
-96.96%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
238.00
-238.00
-100.00%
Net Sales
58.00
1,669.00
-1,611.00
-96.52%
Expenditure (Ex Depriciation)
Stock Adjustments
-9.00
117.00
-126.00
-107.69%
Raw Materials Consumed
51.00
1,250.00
-1,199.00
-95.92%
Power & Fuel Cost
0.00
103.00
-103.00
-100.00%
Employee Cost
2.00
96.00
-94.00
-97.92%
Operating Expenses
0.00
59.00
-59.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
2.00
46.00
-44.00
-95.65%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
3.00
-3.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
49.00
1,699.00
-1,650.00
-97.12%
Operating Profit (PBDIT) excl Other Income
9.00
-29.00
38.00
131.03%
Other Income
0.00
4.00
-4.00
-100.00%
Operating Profit (PBDIT)
9.00
-24.00
33.00
137.50%
Interest
0.00
74.00
-74.00
-100.00%
Profit before Depriciation and Tax
8.00
-99.00
107.00
108.08%
Depreciation
0.00
62.00
-62.00
-100.00%
Profit Before Taxation & Exceptional Items
8.00
-161.00
169.00
104.97%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
8.00
-161.00
169.00
104.97%
Provision for Tax
0.00
-47.00
47.00
100.00%
Profit After Tax
8.00
-113.00
121.00
107.08%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
5.00
703.00
-698.00
-99.29%
Profit Available for appropriations
13.00
590.00
-577.00
-97.80%
Appropriations
13.00
590.00
-577.00
-97.80%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
14.1
-5.07
19.17
378.11%
Profit And Loss - Net Sales
Net Sales 58.27 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 111.71% vs 18.43% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 9.13 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 73.16% vs 47.37% in Mar 2024
Profit And Loss - Interest
Interest 0.51 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -17.20% vs 73.95% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 8.61 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 193.43% vs 73.70% in Mar 2024






